Anti-Human A2AR/ADORA2A Antibody (1B5-3D7)

Anti-Human A2AR/ADORA2A Antibody (1B5-3D7): Enhancing Immune Response Against Cancer and Inflammation

The Anti-Human A2AR/ADORA2A Antibody (1B5-3D7) is a highly specific and potent monoclonal antibody that targets the A2A adenosine receptor (ADORA2A). This receptor is found on the surface of immune cells and plays a crucial role in regulating immune responses.

Biological Function

The A2A adenosine receptor is known to inhibit the activity of immune cells, suppressing their ability to fight against diseases. This is particularly relevant in cancer and inflammatory diseases, where the immune system’s response is often weakened. The Anti-Human A2AR/ADORA2A Antibody (1B5-3D7) blocks the A2A adenosine receptor, allowing immune cells to function at their full potential and effectively fight against cancer and inflammation.

Main Applications

The Anti-Human A2AR/ADORA2A Antibody (1B5-3D7) has been extensively studied and has shown promising results in various preclinical and clinical trials. It has been found to enhance the anti-tumor activity of immune cells, making it a potential therapy for cancer treatment. Additionally, this antibody has shown to reduce inflammation and alleviate symptoms in inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Experimental Use Cases

The Anti-Human A2AR/ADORA2A Antibody (1B5-3D7) has been used in various experimental models to study its effects on immune response. In a study on melanoma, it was found that this antibody significantly increased the infiltration of immune cells into the tumor, leading to tumor regression. In another study on rheumatoid arthritis, it was shown to reduce joint inflammation and bone destruction.

This highly specific and potent monoclonal antibody, Anti-Human A2AR/ADORA2A Antibody (1B5-3D7), targets the A2A adenosine receptor to enhance immune response against cancer and inflammation. Its main applications include cancer treatment and alleviating symptoms of inflammatory diseases. In experimental use cases, it has shown to increase immune cell activity in tumors and reduce inflammation in joints.

Structure

To sum up, the Anti-Human A2AR/ADORA2A Antibody (1B5-3D7) is a powerful tool for enhancing immune response against cancer and inflammation. Its ability to block the A2A adenosine receptor makes it a promising therapy for cancer treatment and inflammatory diseases. Its effectiveness has been demonstrated in various experimental models, making it a valuable asset in the field of biotechnology. Don’t miss the opportunity to incorporate this antibody into your research target and contribute to the advancement of immunotherapy.